Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients
- PMID: 1876514
- DOI: 10.1007/BF02238523
Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients
Abstract
Cardiac examinations were performed on 18 patients with glycogen-storage disease (GSD) type III. Clinical examination was always normal and the electrocardiograms revealed nonspecific data. Similarly, serum muscular enzyme activities were not useful in indicating the presence of cardiomyopathy. Echocardiographic evidence of myocardiopathy was found in five of the 16 children studied (mean age, 9.5 years). Echocardiographic parameters remained stable during the follow-up period (at least 3 years). The other 11 children had no echocardiographic evidence of cardiomyopathy. No relationship was found between peripheral myopathy and cardiomyopathy. All patients with GSD type III should be regularly investigated by echocardiography in respect of their cardiac muscle status.
Similar articles
-
[Determination of blood level of muscle enzymes in glycogenoses with liver involvement: a diagnostic criterion].Ann Pediatr (Paris). 1989 May;36(5):299-301. Ann Pediatr (Paris). 1989. PMID: 2742313 French.
-
Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.Ann Intern Med. 1992 Jun 1;116(11):896-900. doi: 10.7326/0003-4819-116-11-896. Ann Intern Med. 1992. PMID: 1580445
-
[Attempt at appraising the diagnostic usefulness of the determination of creatine phosphokinase, aldolase and lactic dehydrogenase activity in the serum in pediatric diseases].Pol Tyg Lek. 1970 Dec 28;25(52):2020-2. Pol Tyg Lek. 1970. PMID: 5495539 Polish. No abstract available.
-
[Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].Minerva Pediatr. 1981 May 15;33(9):385-412. Minerva Pediatr. 1981. PMID: 7019663 Review. Italian. No abstract available.
-
[Biochemistry of myopathies].Hippokrates. 1967 Dec 15;38(23):909-22. Hippokrates. 1967. PMID: 4891060 Review. German. No abstract available.
Cited by
-
Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice.JCI Insight. 2022 Dec 8;7(23):e152970. doi: 10.1172/jci.insight.152970. JCI Insight. 2022. PMID: 36264632 Free PMC article.
-
Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III.J Inherit Metab Dis. 1995;18(6):751-2. doi: 10.1007/BF02436768. J Inherit Metab Dis. 1995. PMID: 8750616 No abstract available.
-
Characterization of a canine model of glycogen storage disease type IIIa.Dis Model Mech. 2012 Nov;5(6):804-11. doi: 10.1242/dmm.009712. Epub 2012 Jun 26. Dis Model Mech. 2012. PMID: 22736456 Free PMC article.
-
Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review.Int J Mol Sci. 2023 May 11;24(10):8632. doi: 10.3390/ijms24108632. Int J Mol Sci. 2023. PMID: 37239976 Free PMC article.
-
Dietary management in glycogen storage disease type III: what is the evidence?J Inherit Metab Dis. 2015 May;38(3):545-50. doi: 10.1007/s10545-014-9756-x. Epub 2014 Aug 28. J Inherit Metab Dis. 2015. PMID: 25164784 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical